Treatment and prevention strategies for herpes zoster and postherpetic neuralgia in older adults

Clinical Geriatrics

Volumn 14, Issue 1, 2006, Pages 26-33

  Schmader, Kenneth ^a,b  

^a Center for the Study of Aging and Human Development   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMITRIPTYLINE; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; CAPSAICIN; CORTICOSTEROID; DESIPRAMINE; FAMCICLOVIR; GABAPENTIN; LIDOCAINE; MORPHINE; NARCOTIC ANALGESIC AGENT; NORTRIPTYLINE; OXYCODONE; PLACEBO; PREDNISONE; PREGABALIN; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; VALACICLOVIR; VARICELLA ZOSTER VACCINE;

AMBLYOPIA; ANALGESIA; ANTIVIRAL ACTIVITY; APPLICATION SITE BURNING; ARTICLE; BALANCE DISORDER; CARDIOTOXICITY; CLINICAL TRIAL; COGNITIVE DEFECT; CONSTIPATION; DIARRHEA; DIZZINESS; DOSE CALCULATION; DOSE RESPONSE; DROWSINESS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG COMPETITION; DRUG COST; DRUG EFFICACY; DRUG ERUPTION; DRUG EXCRETION; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; EDEMA; GAIT DISORDER; GASTROINTESTINAL SYMPTOM; GRANULOCYTOSIS; HEADACHE; HERPES ZOSTER; HUMAN; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE PRURITUS; INJECTION SITE REACTION; INJECTION SITE SWELLING; NAUSEA AND VOMITING; NONHUMAN; ORTHOSTATIC HYPOTENSION; PERIPHERAL EDEMA; POSTHERPETIC NEURALGIA; PRIMARY PREVENTION; QUALITY OF LIFE; SEDATION; SIDE EFFECT; SKIN MANIFESTATION; SKIN REDNESS; SOMNOLENCE; VACCINATION; VARICELLA ZOSTER VIRUS; VIRUS IMMUNITY; VIRUS INHIBITION; VIRUS REACTIVATION; VIRUS REPLICATION; VISUAL DISORDER; XEROSTOMIA;

EID: 32044470490     PISSN: 10951598     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Cohen JI, Brunell PA, Straus SE, Krause PR. Recent advances in varicella-zoster virus infection. Ann Intern Med 1999;130: 922-932.
2. Hope-Simpson RE. The nature of herpes zoster: A long-term study and new hypothesis. Proc R Soc Med 1965;58:9-20.
3. Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Arch Intern Med 1995;155:1605-1609.
4. Jung BF, Johnson RW, Griffin DR, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004;62:1545-1551.
5. Choo PW, Galil K, Donahue JG, et al. Risk factors for postherpetic neuralgia. Arch Intern Med 1997;157:1217-1224.
6. Wood MJ, Kay R, Dworkin RH, et al. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: A meta-analysis of placebo-controlled trials. Clin Infect Dis 1996;22:341-347.
7. Tyring S, Barbarash RA, Nahlik JE, et al. Famciclovir for the treatment of acute herpes zoster: Effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group. Ann Intern Med 1995;123:89-96.
8. Beutner KR, Friedman DJ, Forszpaniak C, et al. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemotherapy 1995;39:1546-1553.
9. Esmann V, Geil JP, Kroon S, et al. Prednisolone does not prevent postherpetic neuralgia. Lancet 1987;2:126-129.
10. Wood MJ, Johnson RW, McKendrick MW, et al. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994;330:896-900.
11. Whitley RJ, Weiss H, Gnann JW, et al. Acyclovir with and without prednisone for the treatment of herpes zoster: A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med 1996;125:376-383.
12. Dubinsky RH, Kabbani H, El-Chami Z, Boutwell C, Ali H. Practice parameter: Treatment of postherpetic neuralgia. An evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004;63:959-965.
13. Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003;60:1524-1534.
14. Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: Double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996;65:39-44.
15. Galer BS, Rowbotham MC, Perander J, Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: Results of an enriched enrollment study. Pain 1999;80:533-538.
16. Meier T, Wasner G, Faust M, et al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: A randomized, double-blind, placebo-controlled study. Pain 2003;106:151-158.
17. Bernstein JE, Korman NJ, Bickers DR, et al. Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Dermatol 1989;21(2 Pt 1):265-270.
18. Watson CPN, Tyler KL, Bickers DR, et al. A randomized, vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther 1993;15:510-526.
19. Rowbotham MC, Harden N, Stacey B, et al. Gabapentin for the treatment postherpetic neuralgia: A randomized controlled trial. JAMA 1998;280:1837-1842.
20. Rice ASC, Maton S; Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: A randomised, double-blind, placebo-controlled study. Pain 2001;94:215-224.
21. Dworkin RH, Corbin AE, Young JP Jr, et al. Pregabolin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology 2003;60:1274-1283.
22. Max MB. Thirteen consecutive well-designed randomized trials show that antidepressants reduce pain in diabetic neuropathy and postherpetic neuralgia. Pain Forum 1995;4:248-253.
23. Watson CP, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: A randomized trial. Neurology 1998;51:1166-1171.
24. Roose SP, Laghrissi-Thode F, Kennedy JS, et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 1998;279:287-291.
25. Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: A randomized trial in postherpetic neuralgia. Neurology 1998;50:1837-1841.
26. Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology 2002;59:1015-1021.
27. Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in post-herpetic neuralgia: A randomized, double-blind, placebo-controlled trial. Pain 2003;104:323-331.
28. Centers for Disease Control and Prevention. National, State, and Urban Area Vaccination Levels Among Children Aged 19-35 Months - United States, 2002. MMWR 2003;52:728-732. Available at: www.cdc.gov/mmwr/ preview/mmwrhtml/mn5231a2.htm. Accessed November 2, 2005.
29. Berger R, Trannoy E, Hollander G, et al. A dose-response study of a live attenuated varicella-zoster virus (Oka strain) vaccine administered to adults 55 years of age and older. J Infect Dis 1998;178(suppl 1):S99-S103.
30. Levin MJ, Barber D, Goldblatt E, et al. Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: Duration of booster effect. J Infect Dis 1998;178:S109-S112.
31. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al; Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005;352:2271-2284.